These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 8108124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
    Isshiki K, Seng BA, Elder DE, Guerry D, Linnenbach AJ.
    Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS, Clayton RN.
    Cancer Res; 1997 Jul 01; 57(13):2703-9. PubMed ID: 9205080
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Melanoma ex naevo: a study of the associated naevus.
    Bogdan I, Smolle J, Kerl H, Burg G, Böni R.
    Melanoma Res; 2003 Apr 01; 13(2):213-7. PubMed ID: 12690309
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 11. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 12. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group.
    James CD, He J, Collins VP, Allalunis-Turner MJ, Day RS.
    Cancer Res; 1993 Aug 15; 53(16):3674-6. PubMed ID: 8339274
    [Abstract] [Full Text] [Related]

  • 13. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
    Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JC.
    Cancer Res; 1994 Aug 01; 54(15):4003-6. PubMed ID: 8033130
    [Abstract] [Full Text] [Related]

  • 18. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M, Takahashi K, Nagayama K, Arai Y, Ito N, Okada M, Minna JD, Yokota J, Kohno T.
    Genes Chromosomes Cancer; 2005 Dec 01; 44(4):405-14. PubMed ID: 16114034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.